State of the Union on Pharmaceutical Law in Canada

Held on Thursday, September 6, 2018

Biologics litigation, the first cases under the new PMNOC Regulations, the first Certificates of Supplementary Protection issued (and the first rejection!), patent prosecution developments and Galderma headed to the FCA : 2018 has been an exciting year in Canadian pharmaceutical law so far.  Join IPIC’s Life Science Subcommittee for all the latest and greatest on these topics and more.

Melanie Szweras
Bereskin & Parr LLP
Andrew Skodyn
Blake, Cassels & Graydon LLP
Mee Ling Wong
Wilson Lue LLP
Emily Kettel
Bennett Jones LLP

Continuing Professional Development

Law Society of Ontario1
Barreau du Québec1
Law Society of British Columbia1
Law Society of Saskatchewan**
Law Society of Manitoba1
Law Society of Alberta1
New York State CLE Board1
Law Society of New Brunswick1

** An application for accreditation of the session will be submitted upon request by a participant